The semaglutide pen for weight loss: what it is and how to use it

What exactly is inside the semaglutide pen, and how does it work?

Semaglutide is a GLP-1 receptor agonist — a synthetic version of a hormone your gut releases naturally after eating. Once injected, it binds to GLP-1 receptors in the brain and digestive system, slowing the rate at which your stomach empties and reducing the appetite signals that drive you to eat between meals. The result is that many people feel full sooner and stay fuller for longer, making it easier to sustain a reduced-calorie diet alongside treatment.

The Wegovy pen delivers semaglutide as a clear, colourless solution via a fine needle. Each pen is pre-filled and pre-set to the dose your prescriber has selected, so there is no measuring or drawing up of medicine. The needle is hidden inside a protective cap, which helps with any nervousness around injections. A full explanation of the device's mechanics, including the dose window, is in the patient information leaflet that comes with your pen, always read it before your first injection. For more on what semaglutide is and how it fits into weight management, the Wegovy overview goes into further detail.

In the STEP 1 clinical trial (68 weeks, adults with obesity, no diabetes), participants using semaglutide 2.4 mg alongside lifestyle changes achieved an average body-weight reduction of around 15%, compared with around 2.4% in the placebo group, as published in the New England Journal of Medicine. These are average figures from a controlled trial, individual results depend on adherence, diet, activity and individual biology.

Where do you inject the semaglutide pen, and how is the technique done correctly?

The three licensed injection sites are the abdomen (at least a couple of centimetres from the navel), the front of the thigh, and the upper arm. Rotating between sites each week reduces the risk of skin changes at any one spot, so if you used your abdomen last week, try a thigh this week. Clean the skin first with an alcohol swab and let it dry fully before injecting; medical-grade swabs are the right tool for the job.

The pen is pressed firmly against the skin at a 90-degree angle. When you press the injection button, the device drives the needle in and delivers the dose automatically, you hold it in place for several seconds until you hear or feel the injection complete, then release. There is no need to pinch the skin for most adults. After the injection, the needle retracts and locks safely inside the device. A step-by-step walkthrough of the full process is on our semaglutide injection technique page.

Used needles and pens count as sharps waste. They should go into an approved sharps container rather than the household bin. If you need one, a 1-litre sharps bin is the standard size for home use. Your local council or pharmacy can advise on collection.

Storage matters too: the pen is kept in the fridge at 2–8°C until you need it. There is a limited window for room-temperature storage once it has been removed from the fridge, the exact duration is in the patient information leaflet, and following that is not optional.

What dose schedule does the semaglutide pen follow, and can you change it yourself?

Wegovy's titration schedule runs from 0.25 mg (starter dose) through 0.5 mg, 1.0 mg and 1.7 mg, up to the standard maintenance dose of 2.4 mg. A higher 7.2 mg dose was approved by the MHRA in January 2026, with a dedicated single-dose pen for that strength approved on 14 April 2026. In every case, the prescriber decides which dose is right for you and when to move up, the schedule is not something to adjust on your own.

The starting dose is low deliberately. Gastric-emptying slows from the first injection, but the 0.25 mg level is primarily about letting your system adjust before the therapeutic doses kick in. Moving too fast typically means worse nausea. If side effects at any stage are difficult, talk to your prescriber before making any changes, pausing, staying at a dose longer, or stepping back are all clinical decisions, not self-service ones. You can read about the specifics of different pen formats on the semaglutide pens page, or look at the 3 ml pen if you have questions about a specific device format you have seen mentioned, and if you are considering a higher-strength option, the semaglutide 4mg pen page covers what that format involves.

Missed a dose? The patient information leaflet gives clear guidance on the timing window. The short version: if it is within a certain number of days of the missed dose, you can take it; if the next scheduled dose is too close, skip that one and resume your usual day. The leaflet has the exact figures; your prescriber or our aftercare team are there to clarify.

What side effects should you know about before using the semaglutide pen?

Most side effects from the semaglutide pen are gastrointestinal. Nausea is the most commonly reported, and it tends to arrive in the day or two after an injection, then ease off between doses. Constipation, loose stools, indigestion, burping and reflux are also reported, and most people find these settle as their body adapts, particularly once they have been on a stable dose for a few weeks.

Less commonly, people experience fatigue, headaches or dizziness, particularly early in treatment. Injection-site reactions (mild redness or tenderness) can occur but generally resolve quickly.

There are symptoms that need prompt medical attention. Severe, persistent stomach pain that spreads toward the back (with or without vomiting) may be a sign of acute pancreatitis, which the MHRA highlighted in a Drug Safety Update in January 2026 as a known but infrequent serious risk of GLP-1 medicines. Seek urgent help for that. Gallbladder symptoms (upper-right abdominal pain, fever, jaundice) also warrant a same-day call. Signs of a serious allergic reaction (throat swelling, difficulty breathing, rash) mean calling 999.

Semaglutide is not recommended during pregnancy, while breastfeeding, or if you are trying to conceive. It is not licensed for anyone under 18. If you suspect any side effect, you can report it directly to the MHRA via the Yellow Card scheme. And if you are wondering whether semaglutide suits your situation, speaking to our prescribers is the right next step, details on getting started are on the weight loss treatments page.